Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This special notice, issued by the National Institutes of Health under the Department of Health and Human Services, focuses on research regarding the therapeutic role of soluble adenylyl cyclase inhibition in reducing inflammatory vascular remodeling associated with pulmonary arterial hypertension. The project is managed by the NHLBI office located in Bethesda, Maryland, and falls under the NAICS code 621511 for medical laboratories. The solicitation, identified by number 75N98026Q01067, was posted on August 28, 2026, with a response deadline of September 4, 2026. Natalie E. Bruning serves as the primary point of contact for this opportunity.
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Nhlbi
Same awarding agency
